ADAD (Huaizhong Health Group) 3-Year EBITDA Growth Rate: 0.00% (As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADAD Huaizhong Health Group Inc ADAD
34 GF Score
Price $0.00
View Full Analysis

What is Huaizhong Health Group 3-Year EBITDA Growth Rate?

Huaizhong Health Group ADAD 34 3-Year EBITDA Growth Rate is 0.00% as of Jan. 2023. GuruFocus rates ADAD with a GF Score™ of 34/100.

Huaizhong Health Group's EBITDA per Share for the three months ended in Jan. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Huaizhong Health Group  (OTCPK:ADAD) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Huaizhong Health Group 3-Year EBITDA Growth Rate Related Terms

ADAD vs AMRR, NLSC, CLOW: 3-Year EBITDA Growth Rate Comparison

For the Shell Companies subindustry, Huaizhong Health Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huaizhong Health Group 3-Year EBITDA Growth Rate vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Huaizhong Health Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Huaizhong Health Group's 3-Year EBITDA Growth Rate falls into.


ADAD
34GF Score
Huaizhong Health Group Inc ADAD
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huaizhong Health Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Huaizhong Health Group (ADAD) has a 3-Year EBITDA Growth Rate of 0.00% as of Jan. 2023. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Huaizhong Health Group and its competitors.
Is Huaizhong Health Group's 3-Year EBITDA Growth Rate too high?
Huaizhong Health Group's current 3-Year EBITDA Growth Rate is 0.00%. Overall, Huaizhong Health Group has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Huaizhong Health Group's 3-Year EBITDA Growth Rate compare to AMRR and NLSC?
Huaizhong Health Group's 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Diversified Financial Services industry. The industry median 3-Year EBITDA Growth Rate is 18.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Diversified Financial Services company?
The median 3-Year EBITDA Growth Rate among Diversified Financial Services companies is 18.40, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Huaizhong Health Group and its competitors. For the Diversified Financial Services industry, the median 3-Year EBITDA Growth Rate is 18.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huaizhong Health Group's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huaizhong Health Group stock overvalued right now?
Huaizhong Health Group (ADAD) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Huaizhong Health Group's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Huaizhong Health Group (ADAD), the current 3-Year EBITDA Growth Rate is 0.00% as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Huaizhong Health Group Business Description

Address 555 Panyu North Avenue, 13th Floor, Headquarters Center Building 16, Tianan Technology Park, Panyu District, Guangzhou, CHN, 523857
Huaizhong Health Group Inc is a shell company. It is, however, seeking to identify, locate, and, if warranted, acquire new commercial opportunities.
34GF Score

Get the complete analysis for ADAD

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price